Cargando…
Protocol for Designing Small-Molecule-Regulated Destabilizing Domains for In Vitro Use
The use of destabilizing domains (DDs) to conditionally control the abundance of a protein of interest (POI) through a small-molecule stabilizer has gained increasing traction both in vitro and in vivo. Yet there are specific considerations for the development and accurate control of user-defined PO...
Autores principales: | Ramadurgum, Prerana, Hulleman, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521665/ https://www.ncbi.nlm.nih.gov/pubmed/32995752 http://dx.doi.org/10.1016/j.xpro.2020.100069 |
Ejemplares similares
-
Protocol for In Vivo Evaluation and Use of Destabilizing Domains in the Eye, Liver, and Beyond
por: Ramadurgum, Prerana, et al.
Publicado: (2020) -
Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and aging
por: Peng, Hui, et al.
Publicado: (2022) -
Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains In Vivo
por: Peng, Hui, et al.
Publicado: (2019) -
Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization
por: Woodard, DaNae R., et al.
Publicado: (2021) -
A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein
por: Laselva, Onofrio, et al.
Publicado: (2022)